209 related articles for article (PubMed ID: 24425853)
1. Disruption of the blood-aqueous barrier and lens abnormalities in mice lacking lysyl oxidase-like 1 (LOXL1).
Wiggs JL; Pawlyk B; Connolly E; Adamian M; Miller JW; Pasquale LR; Haddadin RI; Grosskreutz CL; Rhee DJ; Li T
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):856-64. PubMed ID: 24425853
[TBL] [Abstract][Full Text] [Related]
2. Transgenic lysyl oxidase homolog 1 overexpression in the mouse eye results in the formation and release of protein aggregates.
Zadravec P; Braunger BM; Melzer B; Kroeber M; Bösl MR; Jägle H; Schlötzer-Schrehardt U; Tamm ER
Exp Eye Res; 2019 Feb; 179():115-124. PubMed ID: 30399364
[TBL] [Abstract][Full Text] [Related]
3. LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma.
Schlötzer-Schrehardt U; Hammer CM; Krysta AW; Hofmann-Rummelt C; Pasutto F; Sasaki T; Kruse FE; Zenkel M
Ophthalmology; 2012 Sep; 119(9):1832-43. PubMed ID: 22633114
[TBL] [Abstract][Full Text] [Related]
4. Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome.
Zenkel M; Schlötzer-Schrehardt U
J Glaucoma; 2014; 23(8 Suppl 1):S48-50. PubMed ID: 25275906
[TBL] [Abstract][Full Text] [Related]
5. Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients.
Schlötzer-Schrehardt U; Pasutto F; Sommer P; Hornstra I; Kruse FE; Naumann GO; Reis A; Zenkel M
Am J Pathol; 2008 Dec; 173(6):1724-35. PubMed ID: 18974306
[TBL] [Abstract][Full Text] [Related]
6. LOXL1 expression in lens capsule tissue specimens from individuals with pseudoexfoliation syndrome and glaucoma.
Khan TT; Li G; Navarro ID; Kastury RD; Zeil CJ; Semchyshyn TM; Moya FJ; Epstein DL; Gonzalez P; Challa P
Mol Vis; 2010 Nov; 16():2236-41. PubMed ID: 21139690
[TBL] [Abstract][Full Text] [Related]
7. Correlation of Aqueous Humor Lysyl Oxidase Activity with TGF-ß Levels and LOXL1 Genotype in Pseudoexfoliation.
Gayathri R; Coral K; Sharmila F; Sripriya S; Sripriya K; Manish P; Shantha B; Ronnie G; Vijaya L; Narayanasamy A
Curr Eye Res; 2016 Oct; 41(10):1331-1338. PubMed ID: 27116380
[TBL] [Abstract][Full Text] [Related]
8. Ocular and systemic manifestations of exfoliation syndrome.
Ritch R
J Glaucoma; 2014; 23(8 Suppl 1):S1-8. PubMed ID: 25275896
[TBL] [Abstract][Full Text] [Related]
9. Integral role for lysyl oxidase-like-1 in conventional outflow tissue function and behavior.
Li G; Schmitt H; Johnson WM; Lee C; Navarro I; Cui J; Fleming T; Gomez-Caraballo M; Elliott MH; Sherwood JM; Hauser MA; Farsiu S; Ethier CR; Stamer WD
FASEB J; 2020 Aug; 34(8):10762-10777. PubMed ID: 32623782
[TBL] [Abstract][Full Text] [Related]
10. Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people.
Hewitt AW; Sharma S; Burdon KP; Wang JJ; Baird PN; Dimasi DP; Mackey DA; Mitchell P; Craig JE
Hum Mol Genet; 2008 Mar; 17(5):710-6. PubMed ID: 18037624
[TBL] [Abstract][Full Text] [Related]
11. Exfoliation Syndrome: A Disease of Autophagy and LOXL1 Proteopathy.
Bernstein AM; Ritch R; Wolosin JM
J Glaucoma; 2018 Jul; 27 Suppl 1(Suppl 1):S44-S53. PubMed ID: 29547474
[TBL] [Abstract][Full Text] [Related]
12. Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1.
Yu HG; Liu X; Kiss S; Connolly E; Gragoudas ES; Michaud NA; Bulgakov OV; Adamian M; DeAngelis MM; Miller JW; Li T; Kim IK
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2599-605. PubMed ID: 18296663
[TBL] [Abstract][Full Text] [Related]
13. Lysyl oxidase-like protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population.
Mossböck G; Renner W; Faschinger C; Schmut O; Wedrich A; Weger M
Mol Vis; 2008 May; 14():857-61. PubMed ID: 18483563
[TBL] [Abstract][Full Text] [Related]
14. Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome.
Zenkel M; Krysta A; Pasutto F; Juenemann A; Kruse FE; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8488-95. PubMed ID: 21948647
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent iris abnormalities in collagen XVIII/endostatin deficient mice with similarities to human pigment dispersion syndrome.
Marneros AG; Olsen BR
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2367-72. PubMed ID: 12766032
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma.
Aragon-Martin JA; Ritch R; Liebmann J; O'Brien C; Blaaow K; Mercieca F; Spiteri A; Cobb CJ; Damji KF; Tarkkanen A; Rezaie T; Child AH; Sarfarazi M
Mol Vis; 2008 Mar; 14():533-41. PubMed ID: 18385788
[TBL] [Abstract][Full Text] [Related]
17. Update on pseudoexfoliation syndrome pathogenesis and associations with intraocular pressure, glaucoma and systemic diseases.
Anastasopoulos E; Founti P; Topouzis F
Curr Opin Ophthalmol; 2015 Mar; 26(2):82-9. PubMed ID: 25594764
[TBL] [Abstract][Full Text] [Related]
18. Blood-aqueous barrier in pseudoexfoliation syndrome: evaluation by immunohistochemical staining of endogenous albumin.
Küchle M; Vinores SA; Mahlow J; Green WR
Graefes Arch Clin Exp Ophthalmol; 1996 Jan; 234(1):12-8. PubMed ID: 8750845
[TBL] [Abstract][Full Text] [Related]
19. Variations in LOXL1 associated with exfoliation glaucoma do not affect amine oxidase activity.
Kim S; Kim Y
Mol Vis; 2012; 18():265-70. PubMed ID: 22328822
[TBL] [Abstract][Full Text] [Related]
20. Differential Lysyl oxidase like 1 expression in pseudoexfoliation glaucoma is orchestrated via DNA methylation.
Greene AG; Eivers SB; McDonnell F; Dervan EWJ; O'Brien CJ; Wallace DM
Exp Eye Res; 2020 Dec; 201():108349. PubMed ID: 33188817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
